Clinical Trials List
2025-07-01 - 2029-06-30
Phase II
Recruiting2
ICD-10D06.0
Carcinoma in situ of endocervix
ICD-10D06.1
Carcinoma in situ of exocervix
ICD-10D06.7
Carcinoma in situ of other parts of cervix
ICD-10D06.9
Carcinoma in situ of cervix, unspecified
ICD-9233.1
Carcinoma in situ of cervix uteri
-
Trial Applicant
Linical
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 陳楨瑞 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Angel Chao Division of Obstetrics & Gynecology
- Yun-Hsin Tang Division of Obstetrics & Gynecology
- 容世明 Division of Others -
- 黃寬仁 Division of Obstetrics & Gynecology
- HSIU-JUNG TUNG Division of Obstetrics & Gynecology
- Min-Yu Chen Division of Obstetrics & Gynecology
- Ting-Chang Chang Division of Obstetrics & Gynecology
- Cheng-Tao Lin Division of Obstetrics & Gynecology
- 張宸邠 Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
- 陳威君 Division of Obstetrics & Gynecology
- 張淑涵 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
128 participants
-
Global
138 participants
